Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer.

Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Lundström KL, Janson C, Birath E, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M.

Med Oncol. 2012 Dec;29(5):3176-82. doi: 10.1007/s12032-012-0247-3. Epub 2012 May 8.

PMID:
22565809
2.

[Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer].

Boddu P, Villlines D, Aklilu M.

Zhongguo Fei Ai Za Zhi. 2016 Nov 20;19(11):725-730. Chinese.

4.

The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy.

Holgersson G, Bergstrom S, Hallqvist A, Liv P, Nilsson J, Willen L, Nyman J, Ekman S, Henriksson R, Bergqvist M.

Neoplasma. 2017;64(6):909-915. doi: 10.4149/neo_2017_614.

PMID:
28895417
5.

Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.

Gao L, Zhang H, Zhang B, Zhang L, Wang C.

Oncotarget. 2017 Feb 28;8(9):15632-15641. doi: 10.18632/oncotarget.14921.

6.

An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.

PMID:
16029805
7.

Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

Du G, Yang Y, Zhang Y, Sun T, Liu W, Wang Y, Li J, Zhang H.

Cancer Chemother Pharmacol. 2013 Apr;71(4):893-904. doi: 10.1007/s00280-013-2080-6. Epub 2013 Jan 26. Erratum in: Cancer Chemother Pharmacol. 2013 Jul;72(1):275. Yang, Yingming [corrected to Yang, Yiming].

PMID:
23355038
8.

A laboratory prognostic index model for patients with advanced non-small cell lung cancer.

Ulas A, Turkoz FP, Silay K, Tokluoglu S, Avci N, Oksuzoglu B, Alkis N.

PLoS One. 2014 Dec 4;9(12):e114471. doi: 10.1371/journal.pone.0114471. eCollection 2014.

9.

Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.

Ji Y, Sheng L, Du X, Qiu G, Su D.

Platelets. 2015;26(2):138-42. doi: 10.3109/09537104.2014.888547. Epub 2014 Mar 28.

PMID:
24679181
10.

Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer.

Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T.

Anticancer Res. 2009 Jul;29(7):2687-90.

11.

[Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].

Li Y, Wei S, Wang J, Hong L, Cui L, Wang C.

Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Chinese.

12.
13.

Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer.

Tomita M, Shimizu T, Ayabe T, Onitsuka T.

Gen Thorac Cardiovasc Surg. 2010 Nov;58(11):573-6. doi: 10.1007/s11748-010-0647-2. Epub 2010 Nov 11.

PMID:
21069496
14.

Survival predictors in advanced non-small cell lung cancer.

Hespanhol V, Queiroga H, Magalhães A, Santos AR, Coelho M, Marques A.

Lung Cancer. 1995 Dec;13(3):253-67.

PMID:
8719065
15.

Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.

Jeong E, Hyun SH, Moon SH, Cho YS, Kim BT, Lee KH.

Medicine (Baltimore). 2017 Feb;96(5):e5935. doi: 10.1097/MD.0000000000005935.

16.

Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.

Kim KH, Park TY, Lee JY, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Yang SC.

J Korean Med Sci. 2014 Apr;29(4):507-11. doi: 10.3346/jkms.2014.29.4.507. Epub 2014 Apr 1.

17.

Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.

Ni XF, Wu P, Wu CP, Ji M, Wu J, Gu XF, Jiang ZX.

Asia Pac J Clin Oncol. 2015 Dec;11(4):e22-30. doi: 10.1111/ajco.12091. Epub 2014 May 30.

PMID:
24889374
18.

Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.

Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.

Biomed Pharmacother. 2015 Oct;75:185-90. doi: 10.1016/j.biopha.2015.07.026. Epub 2015 Aug 31.

PMID:
26337230
19.

Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.

Lee DS, Park KR, Kim SJ, Chung MJ, Lee YH, Chang JH, Kang JH, Hong SH, Kim MS, Kim YS.

Tumour Biol. 2016 Jan;37(1):619-25. doi: 10.1007/s13277-015-3776-5. Epub 2015 Aug 4.

PMID:
26240025
20.

Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?

Chamogeorgakis T, Anagnostopoulos C, Kostopanagiotou G, Bhora F, Toumpoulis I, Georgiannakis E, Nabong A, Dosios T, Harrison L, Connery C.

Thorac Cardiovasc Surg. 2008 Apr;56(3):148-53. doi: 10.1055/s-2007-989455.

PMID:
18365973

Supplemental Content

Support Center